

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 9.80500580 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 9.80500580 |
| 3 | definitive hemopoiesis (GO:0060216) | 6.82413407 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.59888790 |
| 5 | COPII vesicle coating (GO:0048208) | 6.30942739 |
| 6 | protein retention in ER lumen (GO:0006621) | 5.76204206 |
| 7 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.67068824 |
| 8 | positive regulation of vasculogenesis (GO:2001214) | 5.53790143 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.50719662 |
| 10 | signal peptide processing (GO:0006465) | 5.21351193 |
| 11 | endocrine pancreas development (GO:0031018) | 5.17711856 |
| 12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.07904502 |
| 13 | positive regulation of nuclease activity (GO:0032075) | 4.87099843 |
| 14 | protein maturation by protein folding (GO:0022417) | 4.78255150 |
| 15 | exocrine pancreas development (GO:0031017) | 4.61482169 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 4.52772593 |
| 17 | peptide hormone processing (GO:0016486) | 4.50058553 |
| 18 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.49997014 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 4.45959266 |
| 20 | regulation of nuclease activity (GO:0032069) | 4.45611111 |
| 21 | cellular response to unfolded protein (GO:0034620) | 4.39683310 |
| 22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.35910935 |
| 23 | vesicle coating (GO:0006901) | 4.29318241 |
| 24 | negative regulation of granulocyte differentiation (GO:0030853) | 4.28758177 |
| 25 | sequestering of metal ion (GO:0051238) | 4.27188745 |
| 26 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.25134522 |
| 27 | positive regulation of granulocyte differentiation (GO:0030854) | 4.24815388 |
| 28 | ER-nucleus signaling pathway (GO:0006984) | 4.23664941 |
| 29 | nerve growth factor signaling pathway (GO:0038180) | 4.22453277 |
| 30 | cellular response to topologically incorrect protein (GO:0035967) | 4.21643927 |
| 31 | glandular epithelial cell differentiation (GO:0002067) | 4.15951478 |
| 32 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.09143095 |
| 33 | negative regulation of neurotransmitter transport (GO:0051589) | 4.07503855 |
| 34 | type B pancreatic cell development (GO:0003323) | 4.03720014 |
| 35 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.92002086 |
| 36 | Rap protein signal transduction (GO:0032486) | 3.88656376 |
| 37 | 4-hydroxyproline metabolic process (GO:0019471) | 3.83015086 |
| 38 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.82446882 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.82446882 |
| 40 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.77878229 |
| 41 | glandular epithelial cell development (GO:0002068) | 3.77811645 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 3.71080916 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71080916 |
| 44 | ER overload response (GO:0006983) | 3.69272498 |
| 45 | regulation of vasculogenesis (GO:2001212) | 3.68078031 |
| 46 | response to endoplasmic reticulum stress (GO:0034976) | 3.61135715 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60948992 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55201252 |
| 49 | valine metabolic process (GO:0006573) | 3.50062826 |
| 50 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49331420 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 3.49308163 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.48306117 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.48306117 |
| 54 | rRNA methylation (GO:0031167) | 3.47722847 |
| 55 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.46030381 |
| 56 | megakaryocyte development (GO:0035855) | 3.41431300 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40199687 |
| 58 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.37317370 |
| 59 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.36899152 |
| 60 | response to unfolded protein (GO:0006986) | 3.36615067 |
| 61 | regulation of memory T cell differentiation (GO:0043380) | 3.34820342 |
| 62 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.33817479 |
| 63 | peptidyl-asparagine modification (GO:0018196) | 3.33650287 |
| 64 | positive regulation of glycolytic process (GO:0045821) | 3.30987089 |
| 65 | response to topologically incorrect protein (GO:0035966) | 3.27628586 |
| 66 | macroautophagy (GO:0016236) | 3.26868555 |
| 67 | mature B cell differentiation involved in immune response (GO:0002313) | 3.25670436 |
| 68 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.25075040 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24842495 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.24704856 |
| 71 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.21128171 |
| 72 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.20520412 |
| 73 | regulation of granulocyte differentiation (GO:0030852) | 3.19684213 |
| 74 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.19584364 |
| 75 | cellular response to vitamin D (GO:0071305) | 3.18769806 |
| 76 | endothelium development (GO:0003158) | 3.18375757 |
| 77 | negative regulation of bone resorption (GO:0045779) | 3.16855620 |
| 78 | Peyers patch development (GO:0048541) | 3.16099737 |
| 79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.16099737 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 3.13015801 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.11321374 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11273109 |
| 83 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11273109 |
| 84 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.09624014 |
| 85 | interkinetic nuclear migration (GO:0022027) | 3.08421973 |
| 86 | positive regulation of interleukin-17 production (GO:0032740) | 3.08164493 |
| 87 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.06975833 |
| 88 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.04915699 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.04781444 |
| 90 | protein N-linked glycosylation (GO:0006487) | 3.04121799 |
| 91 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.04117741 |
| 92 | regulation of platelet aggregation (GO:0090330) | 3.03328626 |
| 93 | toxin metabolic process (GO:0009404) | 3.01805117 |
| 94 | peptide catabolic process (GO:0043171) | 3.00964121 |
| 95 | establishment of endothelial barrier (GO:0061028) | 3.00867739 |
| 96 | regulation of female gonad development (GO:2000194) | 3.00670294 |
| 97 | positive regulation of insulin secretion (GO:0032024) | 3.00245273 |
| 98 | regulation of RIG-I signaling pathway (GO:0039535) | 2.96758383 |
| 99 | rRNA modification (GO:0000154) | 2.95786505 |
| 100 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.93025849 |
| 101 | phospholipid scrambling (GO:0017121) | 2.92058650 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91756021 |
| 103 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.91366781 |
| 104 | regulation of regulatory T cell differentiation (GO:0045589) | 2.90658743 |
| 105 | Golgi organization (GO:0007030) | 2.88633452 |
| 106 | cellular zinc ion homeostasis (GO:0006882) | 2.88362411 |
| 107 | sulfur amino acid catabolic process (GO:0000098) | 2.87233437 |
| 108 | drug transmembrane transport (GO:0006855) | 2.85780934 |
| 109 | formation of translation preinitiation complex (GO:0001731) | 2.85766547 |
| 110 | regulation of interleukin-17 production (GO:0032660) | 2.85454669 |
| 111 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81603160 |
| 112 | aggressive behavior (GO:0002118) | 2.81332532 |
| 113 | mature B cell differentiation (GO:0002335) | 2.75787795 |
| 114 | aromatic amino acid family catabolic process (GO:0009074) | 2.75221431 |
| 115 | regulation of T-helper cell differentiation (GO:0045622) | 2.72640256 |
| 116 | intestinal absorption (GO:0050892) | 2.72229849 |
| 117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72134796 |
| 118 | B cell receptor signaling pathway (GO:0050853) | 2.71072929 |
| 119 | regulation of glucokinase activity (GO:0033131) | 2.69713625 |
| 120 | regulation of hexokinase activity (GO:1903299) | 2.69713625 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.69502613 |
| 122 | protein carboxylation (GO:0018214) | 2.69502613 |
| 123 | protein autoprocessing (GO:0016540) | 2.69456810 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.69452454 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 2.68910711 |
| 126 | positive regulation of T cell cytokine production (GO:0002726) | 2.68819548 |
| 127 | response to peptidoglycan (GO:0032494) | 2.68248723 |
| 128 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.64749081 |
| 129 | regulation of establishment of cell polarity (GO:2000114) | 2.64709239 |
| 130 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.64116409 |
| 131 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63323840 |
| 132 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.63311406 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.62536464 |
| 134 | hormone catabolic process (GO:0042447) | 2.61858930 |
| 135 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.61448855 |
| 136 | negative regulation of bone remodeling (GO:0046851) | 2.58914726 |
| 137 | cellular response to vitamin (GO:0071295) | 2.57749262 |
| 138 | alpha-linolenic acid metabolic process (GO:0036109) | 2.57075600 |
| 139 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.57012225 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.56984505 |
| 141 | keratan sulfate catabolic process (GO:0042340) | 2.55120534 |
| 142 | lysine metabolic process (GO:0006553) | 2.54089433 |
| 143 | lysine catabolic process (GO:0006554) | 2.54089433 |
| 144 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.53148291 |
| 145 | insulin secretion (GO:0030073) | 2.52552879 |
| 146 | negative regulation of tissue remodeling (GO:0034104) | 2.51880742 |
| 147 | positive regulation of histone deacetylation (GO:0031065) | 2.51664586 |
| 148 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.49495889 |
| 149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.48991591 |
| 150 | response to hexose (GO:0009746) | 2.48705839 |
| 151 | gland morphogenesis (GO:0022612) | 2.48371088 |
| 152 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.48270787 |
| 153 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.47723144 |
| 154 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.47681956 |
| 155 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.47157858 |
| 156 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.46909607 |
| 157 | positive regulation of peptide hormone secretion (GO:0090277) | 2.46213756 |
| 158 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45430213 |
| 159 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.44218028 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.43345179 |
| 161 | cysteine metabolic process (GO:0006534) | 2.43314478 |
| 162 | epithelial cell fate commitment (GO:0072148) | 2.42806824 |
| 163 | necroptotic process (GO:0070266) | 2.42340520 |
| 164 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.42172656 |
| 165 | response to monosaccharide (GO:0034284) | 2.41342967 |
| 166 | response to glucose (GO:0009749) | 2.41212782 |
| 167 | ribosome assembly (GO:0042255) | 2.40587423 |
| 168 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.39486426 |
| 169 | fatty acid homeostasis (GO:0055089) | 2.39438356 |
| 170 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.39385410 |
| 171 | regulation of T-helper 1 type immune response (GO:0002825) | 2.39221232 |
| 172 | negative regulation of interleukin-17 production (GO:0032700) | 2.38737881 |
| 173 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.38103751 |
| 174 | parental behavior (GO:0060746) | 2.37920470 |
| 175 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.36397649 |
| 176 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34013710 |
| 177 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33926029 |
| 178 | actin nucleation (GO:0045010) | 2.31520257 |
| 179 | histamine secretion (GO:0001821) | 2.31472188 |
| 180 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.31413401 |
| 181 | positive regulation of T cell differentiation (GO:0045582) | 2.31199247 |
| 182 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.30712116 |
| 183 | immunoglobulin mediated immune response (GO:0016064) | 2.30617456 |
| 184 | thyroid gland development (GO:0030878) | 2.30373166 |
| 185 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.30117792 |
| 186 | regulation of germinal center formation (GO:0002634) | 2.29250608 |
| 187 | programmed necrotic cell death (GO:0097300) | 2.28890420 |
| 188 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.28086522 |
| 189 | relaxation of smooth muscle (GO:0044557) | 2.27971050 |
| 190 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.27872550 |
| 191 | response to nerve growth factor (GO:1990089) | 2.27872550 |
| 192 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26415780 |
| 193 | negative regulation of cell killing (GO:0031342) | 2.26415780 |
| 194 | B cell mediated immunity (GO:0019724) | 2.26128254 |
| 195 | positive regulation of interleukin-2 production (GO:0032743) | 2.25352755 |
| 196 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.23843709 |
| 197 | embryonic process involved in female pregnancy (GO:0060136) | 2.23110551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.99874109 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.44436174 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.42952422 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17863198 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.89895982 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.81053875 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54914112 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.35492198 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.27040475 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.05793304 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64637066 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57987702 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53053238 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.51224510 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50832182 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50528035 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.50370823 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49328323 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.43123846 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37594027 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.26676188 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.25834050 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.14971233 |
| 24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.07981860 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07745282 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05806362 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04388390 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93054063 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92078152 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90451675 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81134544 |
| 32 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.80765607 |
| 33 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75896030 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75650579 |
| 35 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.75393935 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75064375 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.74118208 |
| 38 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.69951114 |
| 39 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.61108084 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60671768 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57996612 |
| 42 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.54675584 |
| 43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.54415052 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54046416 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53890044 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49652798 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48258064 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47993898 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43291931 |
| 50 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.43057515 |
| 51 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.41833005 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40415581 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37669795 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37335082 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36907490 |
| 56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36631920 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36405280 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35138627 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34711297 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31861065 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31772921 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31332481 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30857935 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29261785 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28145841 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27786210 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27279027 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26996704 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26925118 |
| 70 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25596308 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23762232 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23380375 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22207936 |
| 74 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.21844062 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21538960 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20398980 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19308806 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18919443 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.18883509 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18246938 |
| 81 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18236956 |
| 82 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.17942020 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17365478 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16803217 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16746041 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16373058 |
| 87 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.15400378 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14727886 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13979649 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13565758 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12608574 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11976569 |
| 93 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11738399 |
| 94 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11738399 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11584687 |
| 96 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10136605 |
| 97 | * MYC_22102868_ChIP-Seq_BL_Human | 1.10099836 |
| 98 | * MYB_26560356_Chip-Seq_TH2_Human | 1.08749092 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08005633 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07516855 |
| 101 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07365330 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07336151 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07253935 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05342983 |
| 105 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04499800 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03329959 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03185506 |
| 108 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02386990 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01769242 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01501135 |
| 111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01174275 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00843655 |
| 113 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00284937 |
| 114 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.99975797 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99045111 |
| 116 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98977626 |
| 117 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97936147 |
| 118 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97936147 |
| 119 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97903173 |
| 120 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97336373 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96676368 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96676368 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95843233 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95472028 |
| 125 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95236671 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94477103 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94244568 |
| 128 | MYB_26560356_Chip-Seq_TH1_Human | 0.93203089 |
| 129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91673288 |
| 130 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.91501248 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90641797 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90230958 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90101423 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88698097 |
| 135 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88641501 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88489005 |
| 137 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88182040 |
| 138 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87910694 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86482970 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85386313 |
| 141 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85359140 |
| 142 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84949089 |
| 143 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.84596605 |
| 144 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84397320 |
| 145 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84186215 |
| 146 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83843024 |
| 147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83636819 |
| 148 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82702439 |
| 149 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82489074 |
| 150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82294232 |
| 151 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82102281 |
| 152 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81320918 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81236504 |
| 154 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81059928 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80941312 |
| 156 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80676668 |
| 157 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80602478 |
| 158 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.79478837 |
| 159 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.78832451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.04834922 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.85602595 |
| 3 | MP0003195_calcinosis | 3.43929829 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.23985367 |
| 5 | MP0005464_abnormal_platelet_physiology | 3.20387075 |
| 6 | MP0005365_abnormal_bile_salt | 3.02310857 |
| 7 | MP0003283_abnormal_digestive_organ | 2.91213640 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.90712523 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.88443858 |
| 10 | MP0002693_abnormal_pancreas_physiology | 2.73367826 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.64591171 |
| 12 | MP0005220_abnormal_exocrine_pancreas | 2.61922603 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.61908662 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.61612943 |
| 15 | MP0004043_abnormal_pH_regulation | 2.59284910 |
| 16 | MP0003252_abnormal_bile_duct | 2.53355278 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.43707256 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.33270152 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.32726776 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.24424388 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.23781005 |
| 22 | MP0009697_abnormal_copulation | 2.19799932 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.17950735 |
| 24 | MP0005360_urolithiasis | 2.17806135 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.17134593 |
| 26 | MP0006054_spinal_hemorrhage | 2.04749037 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 2.03041858 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.03041858 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.99710770 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.97977827 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.96931509 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.88039968 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.85849432 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.85183666 |
| 35 | MP0000681_abnormal_thyroid_gland | 1.84359605 |
| 36 | MP0003303_peritoneal_inflammation | 1.83225115 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.77714020 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.77157014 |
| 39 | MP0009840_abnormal_foam_cell | 1.73748702 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.70363297 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.68266914 |
| 42 | MP0002928_abnormal_bile_duct | 1.65229100 |
| 43 | MP0001664_abnormal_digestion | 1.61166374 |
| 44 | MP0009785_altered_susceptibility_to | 1.59677385 |
| 45 | MP0001800_abnormal_humoral_immune | 1.59538196 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.58761063 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.56507183 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.55710160 |
| 49 | MP0001790_abnormal_immune_system | 1.53704074 |
| 50 | MP0005387_immune_system_phenotype | 1.53704074 |
| 51 | MP0002132_abnormal_respiratory_system | 1.53393987 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.52151714 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.51520584 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49515963 |
| 55 | MP0002398_abnormal_bone_marrow | 1.49011207 |
| 56 | MP0002723_abnormal_immune_serum | 1.47498693 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.45640786 |
| 58 | MP0006082_CNS_inflammation | 1.45596652 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.44059832 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.43168238 |
| 61 | MP0003436_decreased_susceptibility_to | 1.41956853 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.41805179 |
| 63 | MP0002405_respiratory_system_inflammati | 1.41441274 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.40970928 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.40741534 |
| 66 | MP0000609_abnormal_liver_physiology | 1.40702418 |
| 67 | MP0005025_abnormal_response_to | 1.40617317 |
| 68 | MP0001819_abnormal_immune_cell | 1.40087507 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.39753838 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.39543223 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.39315854 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.38736088 |
| 73 | MP0002419_abnormal_innate_immunity | 1.36581964 |
| 74 | MP0003828_pulmonary_edema | 1.30822752 |
| 75 | MP0001756_abnormal_urination | 1.29908469 |
| 76 | MP0005670_abnormal_white_adipose | 1.26837135 |
| 77 | MP0002722_abnormal_immune_system | 1.25262555 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.21889047 |
| 79 | MP0000716_abnormal_immune_system | 1.21473268 |
| 80 | MP0005332_abnormal_amino_acid | 1.20222452 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.19697368 |
| 82 | MP0008961_abnormal_basal_metabolism | 1.19045814 |
| 83 | MP0003566_abnormal_cell_adhesion | 1.17745029 |
| 84 | MP0005165_increased_susceptibility_to | 1.15705752 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.14628066 |
| 86 | MP0001765_abnormal_ion_homeostasis | 1.14478826 |
| 87 | MP0002006_tumorigenesis | 1.14118299 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.13596565 |
| 89 | MP0003868_abnormal_feces_composition | 1.13439564 |
| 90 | MP0005083_abnormal_biliary_tract | 1.11671149 |
| 91 | MP0009278_abnormal_bone_marrow | 1.10939439 |
| 92 | MP0000685_abnormal_immune_system | 1.10650207 |
| 93 | MP0002429_abnormal_blood_cell | 1.09488777 |
| 94 | MP0005409_darkened_coat_color | 1.08130127 |
| 95 | MP0005076_abnormal_cell_differentiation | 1.07854147 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 1.06439321 |
| 97 | MP0005375_adipose_tissue_phenotype | 1.05859925 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 1.05002175 |
| 99 | MP0000613_abnormal_salivary_gland | 1.02165269 |
| 100 | MP0001191_abnormal_skin_condition | 1.01789055 |
| 101 | MP0005166_decreased_susceptibility_to | 1.01438303 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 1.01054290 |
| 103 | MP0005671_abnormal_response_to | 0.99334547 |
| 104 | MP0004019_abnormal_vitamin_homeostasis | 0.98721019 |
| 105 | MP0002254_reproductive_system_inflammat | 0.98628356 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.98548004 |
| 107 | MP0001873_stomach_inflammation | 0.97559286 |
| 108 | MP0003279_aneurysm | 0.97437561 |
| 109 | MP0003075_altered_response_to | 0.95938818 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.95403239 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.94300769 |
| 112 | MP0004484_altered_response_of | 0.93742178 |
| 113 | MP0004947_skin_inflammation | 0.93150549 |
| 114 | MP0003724_increased_susceptibility_to | 0.91022497 |
| 115 | MP0003953_abnormal_hormone_level | 0.90994137 |
| 116 | MP0002168_other_aberrant_phenotype | 0.90377855 |
| 117 | MP0005310_abnormal_salivary_gland | 0.90105371 |
| 118 | MP0003795_abnormal_bone_structure | 0.90016861 |
| 119 | MP0001188_hyperpigmentation | 0.88496586 |
| 120 | MP0004147_increased_porphyrin_level | 0.87983162 |
| 121 | MP0001851_eye_inflammation | 0.87086919 |
| 122 | MP0000858_altered_metastatic_potential | 0.85816660 |
| 123 | MP0000598_abnormal_liver_morphology | 0.83940157 |
| 124 | MP0004084_abnormal_cardiac_muscle | 0.83689365 |
| 125 | MP0001661_extended_life_span | 0.83021721 |
| 126 | MP0003045_fibrosis | 0.82994645 |
| 127 | MP0000462_abnormal_digestive_system | 0.82828532 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.82167426 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.81948294 |
| 130 | MP0003959_abnormal_lean_body | 0.81881300 |
| 131 | MP0005408_hypopigmentation | 0.79530582 |
| 132 | MP0002060_abnormal_skin_morphology | 0.78825630 |
| 133 | MP0009672_abnormal_birth_weight | 0.78036690 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.77941768 |
| 135 | MP0000249_abnormal_blood_vessel | 0.77737684 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.77580253 |
| 137 | MP0005334_abnormal_fat_pad | 0.76821143 |
| 138 | MP0005275_abnormal_skin_tensile | 0.75848247 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.75015698 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.74606206 |
| 141 | MP0002876_abnormal_thyroid_physiology | 0.73669137 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.73459426 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.73132194 |
| 144 | MP0001270_distended_abdomen | 0.72949930 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.72307870 |
| 146 | MP0008057_abnormal_DNA_replication | 0.71018001 |
| 147 | MP0004272_abnormal_basement_membrane | 0.69674245 |
| 148 | MP0005257_abnormal_intraocular_pressure | 0.68668755 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.66471898 |
| 150 | MP0003186_abnormal_redox_activity | 0.66012343 |
| 151 | MP0008469_abnormal_protein_level | 0.64787469 |
| 152 | MP0002098_abnormal_vibrissa_morphology | 0.63471016 |
| 153 | MP0001881_abnormal_mammary_gland | 0.62867179 |
| 154 | MP0010368_abnormal_lymphatic_system | 0.62807838 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.62692086 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.62336838 |
| 157 | MP0005023_abnormal_wound_healing | 0.62111248 |
| 158 | MP0003866_abnormal_defecation | 0.61850992 |
| 159 | MP0002933_joint_inflammation | 0.60628374 |
| 160 | MP0005535_abnormal_body_temperature | 0.58994452 |
| 161 | MP0002971_abnormal_brown_adipose | 0.58448636 |
| 162 | MP0002970_abnormal_white_adipose | 0.58080252 |
| 163 | MP0001764_abnormal_homeostasis | 0.56879186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.56704077 |
| 2 | Hypoglycemic seizures (HP:0002173) | 6.20110206 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.19433958 |
| 4 | Symptomatic seizures (HP:0011145) | 5.31970051 |
| 5 | Hyperglycemia (HP:0003074) | 4.59873024 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.26744732 |
| 7 | Ketoacidosis (HP:0001993) | 4.22654260 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.20823186 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.10764956 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.96035717 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.96035717 |
| 12 | Late onset (HP:0003584) | 3.95276778 |
| 13 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.83578606 |
| 14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.83578606 |
| 15 | Acute lymphatic leukemia (HP:0006721) | 3.67435104 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66011316 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.63729588 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.58664099 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.58664099 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.58664099 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.53001887 |
| 22 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.51270742 |
| 23 | Abnormality of macular pigmentation (HP:0008002) | 3.37260864 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.18689212 |
| 25 | Prolonged bleeding time (HP:0003010) | 3.17714986 |
| 26 | Metaphyseal dysplasia (HP:0100255) | 3.14726019 |
| 27 | Central scotoma (HP:0000603) | 3.13431817 |
| 28 | Ketosis (HP:0001946) | 3.11656422 |
| 29 | Insulin resistance (HP:0000855) | 3.09090512 |
| 30 | Dyschromatopsia (HP:0007641) | 3.06944215 |
| 31 | Acute myeloid leukemia (HP:0004808) | 3.05531792 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.04820991 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 3.04820991 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 3.03555223 |
| 35 | Abnormal pancreas size (HP:0012094) | 3.02293141 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.94522884 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93088251 |
| 38 | Myositis (HP:0100614) | 2.92607589 |
| 39 | Abnormality of the prostate (HP:0008775) | 2.91771181 |
| 40 | Abnormality of B cell number (HP:0010975) | 2.87551337 |
| 41 | Large for gestational age (HP:0001520) | 2.85924599 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.84339391 |
| 43 | Cone-rod dystrophy (HP:0000548) | 2.83263272 |
| 44 | Gout (HP:0001997) | 2.80854639 |
| 45 | Epistaxis (HP:0000421) | 2.77749115 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76150560 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76150560 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76150560 |
| 49 | Decreased central vision (HP:0007663) | 2.69526369 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67949466 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67845130 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.67482987 |
| 53 | Retinal atrophy (HP:0001105) | 2.64700946 |
| 54 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.64075910 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62733670 |
| 56 | B lymphocytopenia (HP:0010976) | 2.61592139 |
| 57 | Xanthomatosis (HP:0000991) | 2.59318126 |
| 58 | Thoracolumbar scoliosis (HP:0002944) | 2.58724074 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.54771978 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.45833009 |
| 61 | Decreased circulating renin level (HP:0003351) | 2.45092795 |
| 62 | Hypokalemia (HP:0002900) | 2.42040833 |
| 63 | Thrombocytosis (HP:0001894) | 2.37716570 |
| 64 | Papilledema (HP:0001085) | 2.35566296 |
| 65 | Gingival bleeding (HP:0000225) | 2.34588323 |
| 66 | Encephalitis (HP:0002383) | 2.32979676 |
| 67 | Abnormal platelet function (HP:0011869) | 2.32291020 |
| 68 | Impaired platelet aggregation (HP:0003540) | 2.32291020 |
| 69 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28732210 |
| 70 | Abdominal distention (HP:0003270) | 2.26867415 |
| 71 | Thickened calvaria (HP:0002684) | 2.26048503 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.25083731 |
| 73 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.24773250 |
| 74 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.24773250 |
| 75 | Chronic diarrhea (HP:0002028) | 2.24311062 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.23220741 |
| 77 | Complement deficiency (HP:0004431) | 2.23068429 |
| 78 | Agammaglobulinemia (HP:0004432) | 2.22093885 |
| 79 | Stomatitis (HP:0010280) | 2.21599312 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.18658525 |
| 81 | Deep venous thrombosis (HP:0002625) | 2.15031522 |
| 82 | Orchitis (HP:0100796) | 2.14235788 |
| 83 | Arterial thrombosis (HP:0004420) | 2.13343987 |
| 84 | Abnormal ciliary motility (HP:0012262) | 2.12985360 |
| 85 | Flat acetabular roof (HP:0003180) | 2.12899120 |
| 86 | Abnormality of T cells (HP:0002843) | 2.12520218 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12346770 |
| 88 | Chronic otitis media (HP:0000389) | 2.12335285 |
| 89 | Protuberant abdomen (HP:0001538) | 2.11174466 |
| 90 | Skin nodule (HP:0200036) | 2.11144555 |
| 91 | Pulmonary embolism (HP:0002204) | 2.10543389 |
| 92 | Prostate neoplasm (HP:0100787) | 2.10025209 |
| 93 | Vasculitis (HP:0002633) | 2.09953761 |
| 94 | Xerostomia (HP:0000217) | 2.09708184 |
| 95 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08837023 |
| 96 | Meningitis (HP:0001287) | 2.08183143 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.08096150 |
| 98 | T lymphocytopenia (HP:0005403) | 2.07891995 |
| 99 | Limb hypertonia (HP:0002509) | 2.06332235 |
| 100 | Progressive neurologic deterioration (HP:0002344) | 2.05769249 |
| 101 | Cervical subluxation (HP:0003308) | 2.05591044 |
| 102 | Exocrine pancreatic insufficiency (HP:0001738) | 2.04968474 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.04874878 |
| 104 | Polygenic inheritance (HP:0010982) | 2.04649206 |
| 105 | Unilateral renal agenesis (HP:0000122) | 2.03856206 |
| 106 | Abolished electroretinogram (ERG) (HP:0000550) | 2.03811857 |
| 107 | Abnormality of chloride homeostasis (HP:0011422) | 2.02246692 |
| 108 | Abnormality of the periventricular white matter (HP:0002518) | 2.02220888 |
| 109 | Fat malabsorption (HP:0002630) | 2.02213448 |
| 110 | Spontaneous hematomas (HP:0007420) | 2.02087147 |
| 111 | Recurrent viral infections (HP:0004429) | 2.01719112 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 2.01016442 |
| 113 | Joint swelling (HP:0001386) | 2.00421517 |
| 114 | Reduced antithrombin III activity (HP:0001976) | 1.99649100 |
| 115 | Abnormal biliary tract morphology (HP:0012440) | 1.99282590 |
| 116 | Pustule (HP:0200039) | 1.97959627 |
| 117 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.97805910 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.94967129 |
| 119 | Alveolar cell carcinoma (HP:0006519) | 1.94087305 |
| 120 | Recurrent abscess formation (HP:0002722) | 1.92326166 |
| 121 | Abnormality of potassium homeostasis (HP:0011042) | 1.91227495 |
| 122 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90645058 |
| 123 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90531990 |
| 124 | Eczematoid dermatitis (HP:0000976) | 1.90013384 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88608468 |
| 126 | Menstrual irregularities (HP:0000858) | 1.88586142 |
| 127 | Recurrent skin infections (HP:0001581) | 1.87480323 |
| 128 | Gastrointestinal inflammation (HP:0004386) | 1.87141831 |
| 129 | Increased cerebral lipofuscin (HP:0011813) | 1.86862827 |
| 130 | Petechiae (HP:0000967) | 1.86158062 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86013169 |
| 132 | Obstructive lung disease (HP:0006536) | 1.86013169 |
| 133 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85214644 |
| 134 | Elevated alkaline phosphatase (HP:0003155) | 1.85031436 |
| 135 | Pulmonary infiltrates (HP:0002113) | 1.84963571 |
| 136 | Keratoconjunctivitis (HP:0001096) | 1.84927123 |
| 137 | Recurrent fungal infections (HP:0002841) | 1.84757358 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.84708444 |
| 139 | Disinhibition (HP:0000734) | 1.84535027 |
| 140 | Optic neuritis (HP:0100653) | 1.84041430 |
| 141 | Retrobulbar optic neuritis (HP:0100654) | 1.84041430 |
| 142 | Beaking of vertebral bodies (HP:0004568) | 1.83812814 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83730823 |
| 144 | Abnormality of renin-angiotensin system (HP:0000847) | 1.82976290 |
| 145 | Osteomalacia (HP:0002749) | 1.80270475 |
| 146 | Hyperkalemia (HP:0002153) | 1.79903731 |
| 147 | Severe short stature (HP:0003510) | 1.79880960 |
| 148 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79682198 |
| 149 | Syringomyelia (HP:0003396) | 1.79362237 |
| 150 | Spinal cord lesions (HP:0100561) | 1.79362237 |
| 151 | Scotoma (HP:0000575) | 1.79287881 |
| 152 | Prolonged partial thromboplastin time (HP:0003645) | 1.78624153 |
| 153 | Aortic aneurysm (HP:0004942) | 1.78384942 |
| 154 | Urticaria (HP:0001025) | 1.78095044 |
| 155 | Hypophosphatemia (HP:0002148) | 1.77993637 |
| 156 | Macular degeneration (HP:0000608) | 1.77785818 |
| 157 | Chest pain (HP:0100749) | 1.77609382 |
| 158 | Prominent metopic ridge (HP:0005487) | 1.77483553 |
| 159 | Abnormality of the lumbar spine (HP:0100712) | 1.76612407 |
| 160 | Progressive visual loss (HP:0000529) | 1.76070893 |
| 161 | Growth hormone excess (HP:0000845) | 1.75155806 |
| 162 | Papillary thyroid carcinoma (HP:0002895) | 1.74438886 |
| 163 | Recurrent bronchitis (HP:0002837) | 1.73558617 |
| 164 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73313808 |
| 165 | Pancreatitis (HP:0001733) | 1.73271946 |
| 166 | Increased CSF protein (HP:0002922) | 1.73232921 |
| 167 | Granulocytopenia (HP:0001913) | 1.72957771 |
| 168 | Cardiomegaly (HP:0001640) | 1.72553784 |
| 169 | Cerebral aneurysm (HP:0004944) | 1.72518571 |
| 170 | Thin bony cortex (HP:0002753) | 1.71918386 |
| 171 | Myoglobinuria (HP:0002913) | 1.70434628 |
| 172 | Hyperphosphatemia (HP:0002905) | 1.70174059 |
| 173 | Back pain (HP:0003418) | 1.68846688 |
| 174 | Right ventricular cardiomyopathy (HP:0011663) | 1.67867917 |
| 175 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.67799492 |
| 176 | Aneurysm (HP:0002617) | 1.67448620 |
| 177 | Macroorchidism (HP:0000053) | 1.67296797 |
| 178 | Irritability (HP:0000737) | 1.66666368 |
| 179 | Hypotension (HP:0002615) | 1.66206861 |
| 180 | Systemic lupus erythematosus (HP:0002725) | 1.65412369 |
| 181 | Hypokalemic alkalosis (HP:0001949) | 1.64767443 |
| 182 | Hypoplasia of the thymus (HP:0000778) | 1.63978276 |
| 183 | Acute hepatic failure (HP:0006554) | 1.62821906 |
| 184 | Agitation (HP:0000713) | 1.61915541 |
| 185 | Hyperbilirubinemia (HP:0002904) | 1.60704640 |
| 186 | Hyperuricemia (HP:0002149) | 1.59541098 |
| 187 | Increased purine levels (HP:0004368) | 1.59541098 |
| 188 | Asymmetric septal hypertrophy (HP:0001670) | 1.58451140 |
| 189 | Proximal tubulopathy (HP:0000114) | 1.58386255 |
| 190 | Mitral stenosis (HP:0001718) | 1.57871992 |
| 191 | Glomerulonephritis (HP:0000099) | 1.57499046 |
| 192 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.57287861 |
| 193 | Abnormal protein glycosylation (HP:0012346) | 1.57287861 |
| 194 | Abnormal glycosylation (HP:0012345) | 1.57287861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.10180312 |
| 2 | PASK | 4.02362251 |
| 3 | ERN1 | 4.00960009 |
| 4 | MAPK15 | 3.37605322 |
| 5 | TAOK3 | 3.28470366 |
| 6 | KIT | 3.19217528 |
| 7 | TRIB3 | 2.73316661 |
| 8 | TXK | 2.68650413 |
| 9 | FRK | 2.63654888 |
| 10 | PBK | 2.45283904 |
| 11 | TAF1 | 2.30768825 |
| 12 | FLT3 | 2.24532024 |
| 13 | BCKDK | 2.16666636 |
| 14 | HIPK2 | 2.16261508 |
| 15 | FGFR4 | 2.11835817 |
| 16 | CSF1R | 2.05784548 |
| 17 | MAP3K2 | 2.05735065 |
| 18 | EPHA3 | 1.99167700 |
| 19 | SIK1 | 1.92963738 |
| 20 | MAP4K2 | 1.89238894 |
| 21 | PTK6 | 1.88964580 |
| 22 | MAP3K6 | 1.79142140 |
| 23 | MAP3K3 | 1.59967743 |
| 24 | IRAK3 | 1.59913010 |
| 25 | WNK4 | 1.56891037 |
| 26 | PDGFRA | 1.56454317 |
| 27 | PRKD3 | 1.54750741 |
| 28 | EPHA2 | 1.52470553 |
| 29 | TGFBR2 | 1.50956158 |
| 30 | PKN2 | 1.50425466 |
| 31 | BMPR2 | 1.49945165 |
| 32 | SCYL2 | 1.48890218 |
| 33 | MATK | 1.41584790 |
| 34 | NEK9 | 1.39586084 |
| 35 | PINK1 | 1.38516538 |
| 36 | WNK3 | 1.37216339 |
| 37 | RIPK4 | 1.36289457 |
| 38 | SYK | 1.34266016 |
| 39 | LATS1 | 1.28389251 |
| 40 | PTK2 | 1.28317908 |
| 41 | MAP3K13 | 1.28225388 |
| 42 | AKT3 | 1.27748153 |
| 43 | FGFR3 | 1.27186467 |
| 44 | PIK3CG | 1.26924607 |
| 45 | EPHB1 | 1.24714497 |
| 46 | FES | 1.13583514 |
| 47 | ZAP70 | 1.11809116 |
| 48 | JAK1 | 1.10828934 |
| 49 | JAK3 | 1.09705517 |
| 50 | RPS6KA4 | 1.09101916 |
| 51 | PRKCQ | 1.07150286 |
| 52 | ITK | 1.06927343 |
| 53 | IKBKE | 1.05127741 |
| 54 | RPS6KB2 | 1.02221544 |
| 55 | MAP2K6 | 1.01913326 |
| 56 | IRAK1 | 1.00904027 |
| 57 | GRK6 | 1.00396441 |
| 58 | DYRK1B | 0.99877348 |
| 59 | BRSK2 | 0.99661242 |
| 60 | IKBKB | 0.99150312 |
| 61 | MET | 0.99086906 |
| 62 | MAP3K1 | 0.97662588 |
| 63 | DAPK2 | 0.96190035 |
| 64 | TYK2 | 0.95304847 |
| 65 | NLK | 0.94706325 |
| 66 | JAK2 | 0.93196446 |
| 67 | EIF2AK2 | 0.91883820 |
| 68 | MKNK1 | 0.91748467 |
| 69 | FER | 0.91445343 |
| 70 | LCK | 0.90469114 |
| 71 | MAP3K10 | 0.89577408 |
| 72 | HCK | 0.88658613 |
| 73 | EIF2AK3 | 0.88077338 |
| 74 | CHUK | 0.86818767 |
| 75 | STK24 | 0.85586139 |
| 76 | TRPM7 | 0.82850555 |
| 77 | CLK1 | 0.80002772 |
| 78 | PIK3CA | 0.77295203 |
| 79 | STK10 | 0.76145433 |
| 80 | TESK1 | 0.75453457 |
| 81 | TBK1 | 0.73315700 |
| 82 | MAPKAPK3 | 0.72466664 |
| 83 | MAP2K2 | 0.71953823 |
| 84 | CDK19 | 0.71604862 |
| 85 | TEC | 0.69781621 |
| 86 | MTOR | 0.69292761 |
| 87 | MAPK7 | 0.67542121 |
| 88 | CDK6 | 0.66965352 |
| 89 | RET | 0.65561554 |
| 90 | RIPK1 | 0.64822921 |
| 91 | PRKCH | 0.64699064 |
| 92 | CDC42BPA | 0.64388224 |
| 93 | LYN | 0.64337253 |
| 94 | DAPK1 | 0.60117807 |
| 95 | MST1R | 0.59651648 |
| 96 | RPS6KL1 | 0.59430842 |
| 97 | RPS6KC1 | 0.59430842 |
| 98 | BTK | 0.58684526 |
| 99 | LRRK2 | 0.58590603 |
| 100 | CAMKK2 | 0.57386943 |
| 101 | MAP3K5 | 0.56503431 |
| 102 | PDK2 | 0.56376454 |
| 103 | GSK3A | 0.55880611 |
| 104 | CAMK1D | 0.53438167 |
| 105 | IGF1R | 0.53056706 |
| 106 | CSK | 0.52818296 |
| 107 | MAP3K7 | 0.52058962 |
| 108 | MAP2K3 | 0.51484761 |
| 109 | CDK12 | 0.51476240 |
| 110 | PAK3 | 0.50058115 |
| 111 | RPS6KA6 | 0.49862160 |
| 112 | ABL1 | 0.49799734 |
| 113 | TNK2 | 0.49737272 |
| 114 | STK3 | 0.48261970 |
| 115 | MAP4K1 | 0.46049596 |
| 116 | CDK9 | 0.45954318 |
| 117 | PDGFRB | 0.45566566 |
| 118 | STK39 | 0.45369314 |
| 119 | ACVR1B | 0.44266986 |
| 120 | TIE1 | 0.43602899 |
| 121 | PRKCD | 0.42789512 |
| 122 | RPS6KB1 | 0.41444380 |
| 123 | RAF1 | 0.40879122 |
| 124 | MST4 | 0.40772915 |
| 125 | KDR | 0.39832835 |
| 126 | MELK | 0.39818015 |
| 127 | TGFBR1 | 0.39800500 |
| 128 | PAK4 | 0.38583981 |
| 129 | MAP3K14 | 0.38052006 |
| 130 | PRKAA1 | 0.37950555 |
| 131 | ERBB3 | 0.37817712 |
| 132 | CDK3 | 0.37744915 |
| 133 | PRKG2 | 0.36856915 |
| 134 | PRKD2 | 0.36631743 |
| 135 | FGFR1 | 0.35761151 |
| 136 | STK38L | 0.35459355 |
| 137 | MAPK11 | 0.34895627 |
| 138 | BRD4 | 0.34640767 |
| 139 | NTRK1 | 0.33844694 |
| 140 | MAPK4 | 0.32596306 |
| 141 | GRK1 | 0.32197356 |
| 142 | MARK3 | 0.30619866 |
| 143 | MAPKAPK2 | 0.30172755 |
| 144 | IRAK4 | 0.29661902 |
| 145 | MAP2K1 | 0.29643189 |
| 146 | ERBB4 | 0.29342806 |
| 147 | PRKD1 | 0.27941678 |
| 148 | NUAK1 | 0.25958298 |
| 149 | PAK2 | 0.24840184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.31230152 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.30457249 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.31827756 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.18714194 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66790495 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.58560345 |
| 7 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.52495120 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.45226096 |
| 9 | Platelet activation_Homo sapiens_hsa04611 | 2.37308033 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33721297 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23431325 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09624765 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96377294 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87761361 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85858920 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84873088 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79952157 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76352168 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72468691 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68278931 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68191641 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65595406 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59483978 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.58327236 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.58320936 |
| 26 | * Lysosome_Homo sapiens_hsa04142 | 1.57759912 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57006256 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53150094 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48354899 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48345763 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47027290 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38856610 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.36638019 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.34017939 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30867741 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.28897506 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27836267 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.26936807 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.26870591 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26516076 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24168303 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22925816 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21175915 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16740902 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15651431 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15560864 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15449056 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14272896 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11924045 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11008132 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 1.09357204 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08392988 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08344592 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08193083 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07857878 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 1.07802356 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07655656 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07006200 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06536056 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 1.04844318 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02389054 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 1.02144083 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01185973 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99709006 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98674447 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.98290292 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97440937 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97427259 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.96622004 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95824404 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95350580 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93820930 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93544817 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.92491146 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92367831 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91643278 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.90470529 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90214579 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89909974 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87582638 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86133525 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82656164 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82540382 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82485314 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80640663 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76346503 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75081513 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.72240438 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71314798 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69911953 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69249658 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68533468 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65883642 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65815443 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65391501 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65323446 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64972089 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64832599 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63671705 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63022325 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63004643 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62992281 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61922720 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61670680 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60847584 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59967773 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59723210 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59517999 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59469057 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59273288 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.58544587 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58312671 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58070719 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57714218 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53873453 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.53396413 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52848937 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52391111 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51807321 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51198446 |
| 121 | Bile secretion_Homo sapiens_hsa04976 | 0.51060378 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51025431 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49654467 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.48608055 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.48259892 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46910623 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45567936 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44750802 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44049731 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42230659 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41677854 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41458757 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40730846 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39343381 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37922002 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37087487 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36756667 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36165905 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.35713119 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35571075 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32628805 |
| 142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31740868 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31619896 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30816493 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.29523304 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28303526 |
| 147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25671576 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25372042 |
| 149 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25100309 |
| 150 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25099751 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23423015 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22588012 |
| 153 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22393149 |
| 154 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22136166 |
| 155 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.20291991 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.20207466 |
| 157 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.19630933 |

